One-Year Survival Following Early Revascularization for Cardiogenic Shock

Abstract

Cardiogenic shock (CS) is the leading cause of death for patients hospitalized with acute myocardial infarction (AMI),^1,2 and mortality remains high during the following year.^3,4 The SHOCK (Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock) Trial demonstrated a nonsignificant reduction in 30-day mortality (56% vs 47%) when early revascularization (ERV) was compared with a strategy of initial medical stabilization (IMS), with a larger difference between the groups at 6 months.⁵ In this article, we report the 1-year survival, a prespecified secondary end point of the SHOCK Trial.